Stabilizing endothelium of donor hearts with fusogenic liposomes reduces myocardial injury and dysfunction-Reference-Cited by-同舟云学术

Stabilizing endothelium of donor hearts with fusogenic liposomes reduces myocardial injury and dysfunction

Published:2013-06 Issue:2 Volume:182 Page:331-338
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Fensterer Tathyana F.,Keeling W. Brent,Patibandla Phani K.,Pushpakumar Sathnur,Perez-Abadia Gustavo,Bauer Philip,Soni Chirag V.,Anderson Gary L.,Maldonado Claudio

Publisher

Elsevier BV

Subject

Surgery

Reference31 articles.

1. Cardiac cell survival and reversibility of myocardial ischemia;Rashed;Arch Mal Coeur Vaiss,2006

2. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial “stunning” is a manifestation of reperfusion injury;Bolli;Circ Res,1989

3. Myocardial stunning and reperfusion injury in cardiac surgery;Appleyard;J Card Surg,1993

4. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion;Allen;J Thorac Cardiovasc Surg,1993

5. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support;Cimochowski;J Thorac Cardiovasc Surg,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size;Cardiovascular Drugs and Therapy;2020-10-20

2. Characterization of ATP Nanoliposome Treatment for Regeneration of Injured Spinal Cord;Nanotechnology Characterization Tools for Tissue Engineering and Medical Therapy;2019

3. Intralipid ® attenuates acute cardiac allograft rejection in relation to promoting CD4 + CD25 + Foxp3 + regulatory T-cells and inhibiting toll-like receptor 4 expression;Transplantation Reports;2017-03